Evidence map›Paper›PMID 38089499›Full record

ArticleFrontiers in genome editing2023

Germline ablation achieved via CRISPR/Cas9 targeting of

Maci L Mueller, Bret R McNabb, Joseph R Owen, Sadie L Hennig, Alba V Ledesma, Mitchell L Angove, Alan J Conley, Pablo J Ross, Alison L Van Eenennaam

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genome editing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Male germ cell technologies in large animals.The Journal of reproduction and development · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maci L MuellerDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
Bret R McNabbDepartment of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Joseph R OwenDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
Sadie L HennigDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
Alba V LedesmaDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
Mitchell L AngoveDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
Alan J ConleyDepartment of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Pablo J RossDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
Alison L Van EenennaamDepartment of Animal Science, University of California, Davis, Davis, CA, United States.
University of California, Davis · US

Funding

Acquisition of Covaris E220 and Sciclone G3 systems for high throughput sequencinS10OD010786 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI COMAI, LUCA · 2012 to 2012
$311k
NIH HHS S10 OD010786
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bovineCRISPR/Cas9embryogene editinggermline ablationNANOS3

Identifiers

PMID38089499
PMCPMC10711618
OpenAlexW4389053460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.